NCT06440850 2026-02-02
Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation
City of Hope Medical Center
Phase 2 Recruiting
Clinical Trials
4 trialsNCT06959641 2025-06-11
XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer
Northwestern University
Phase 2 Recruiting
NCT00591643 2015-12-28
Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01250314 2012-07-03
OSTEHOM
Assistance Publique - Hôpitaux de Paris
Phase NA Completed